Sandy Hinckley

Company: QurAlis

Job title: Vice President & Head of Discovery

Seminars:

Reducing the Burden of In Vitro and In Vivo Studies for IND Submission by Streamlining Oligonucleotide Development to the Clinic 1:00 pm

Identifying mis-splicing targets with FlexASO technology to recover loss of TDP- 43 in ALS Using in silico analysis, chemistry and scaffold of the oligonucleotide to forecast candidate toxicity of test material to avoid unexpected toxicity Getting the most out of in vitro studies prior to in vivo studies to give as much credibility as possible…Read more

day: Conference Day Two